Sotigalimab is a CD40 agonistic monoclonal antibody designed to selectively bind to CD40 with high affinity. This interaction promotes the activation of antigen-presenting cells, which in turn enhances cancer-specific T cell responses. Primarily utilized in research focused on metastatic pancreatic cancer and metastatic melanoma, Sotigalimab serves as a critical tool in the investigation of immune-mediated therapies targeting these aggressive cancers.
Sotigalimab is a CD40 agonistic monoclonal antibody designed to selectively bind to CD40 with high affinity. This interaction promotes the activation of antigen-presenting cells, which in turn enhances cancer-specific T cell responses. Primarily utilized in research focused on metastatic pancreatic cancer and metastatic melanoma, Sotigalimab serves as a critical tool in the investigation of immune-mediated therapies targeting these aggressive cancers.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
